<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress/2.1.2" -->
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	>

<channel>
	<title>Skin Cancer</title>
	<link>http://skincancerlive.com</link>
	<description>Just another WordPress weblog</description>
	<pubDate>Mon, 26 May 2008 16:25:34 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.1.2</generator>
	<language>en</language>
			<item>
		<title>Mole Removal Basics</title>
		<link>http://skincancerlive.com/2008/05/26/mole-removal-basics/</link>
		<comments>http://skincancerlive.com/2008/05/26/mole-removal-basics/#comments</comments>
		<pubDate>Mon, 26 May 2008 16:25:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Mole Removal Basics]]></category>

		<guid isPermaLink="false">http://skincancerlive.com/archives/22</guid>
		<description><![CDATA[After removal, moles may leave a scar or re-grow.
Most moles are harmless and don&#8217;t need to be removed, but you do need to be aware that some forms of skin cancer can begin by looking like a mole. If you have a mole that has changed in any way-including size, colour, shape-or begins to bleed, see [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNormal" style="text-align: justify"><strong><span style="font-size: 10pt; color: black" lang="EN">After removal, moles may leave a scar or re-grow.</span></strong><span style="font-size: 10pt; color: black" lang="EN"><o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; color: black" lang="EN">Most moles are harmless and don&#8217;t need to be removed, but you do need to be aware that some forms of skin cancer can begin by looking like a mole. If you have a mole that has changed in any way-including size, colour, shape-or begins to bleed, see your doctor right away. <o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><strong><span style="font-size: 10pt; color: black" lang="EN">How it&#8217;s done<o:p></o:p></span></strong></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; color: black" lang="EN">This is usually an in-office procedure performed by your doctor, although he or she may refer you to a specialist. <o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><strong><span style="font-size: 10pt; color: black" lang="EN">Recovery</span></strong><span style="font-size: 10pt; color: black" lang="EN"><br />
Scab will heal within 1 to 2 weeks. <o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><strong><span style="font-size: 10pt; color: black" lang="EN">Complications</span></strong><span style="font-size: 10pt; color: black" lang="EN"><br />
After removal, moles may leave a scar or re-grow.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><strong><span style="font-size: 10pt; color: black" lang="EN">Cost</span></strong><span style="font-size: 10pt; color: black" lang="EN"><br />
$25 to $200.<o:p></o:p></span></p>
<p class="akst_link"><a href="http://skincancerlive.com/?p=22&amp;akst_action=share-this"  title="E-mail this, post to del.icio.us, etc." id="akst_link_22" class="akst_share_link" rel="nofollow">Share This</a>
</p>]]></content:encoded>
			<wfw:commentRss>http://skincancerlive.com/2008/05/26/mole-removal-basics/feed/</wfw:commentRss>
		</item>
		<item>
		<title>SKIN CANCER</title>
		<link>http://skincancerlive.com/2008/05/26/skin-cancer-6/</link>
		<comments>http://skincancerlive.com/2008/05/26/skin-cancer-6/#comments</comments>
		<pubDate>Mon, 26 May 2008 16:25:06 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[SKIN CANCER -5]]></category>

		<guid isPermaLink="false">http://skincancerlive.com/archives/21</guid>
		<description><![CDATA[The Cancer Council Australia&#8217;s CEO, Professor Ian Olver, said results from the National Sun Protection Survey showed there had been a &#8220;remarkable turnaround&#8221; in attitudes to tanning. 
&#8220;On one hand this is very encouraging, however the bad news is one in four teenagers is still getting burnt, not because they want to get a tan [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNormal" style="text-align: justify"><span class="nnl"><span style="font-size: 10pt; color: black">The Cancer Council Australia&#8217;s CEO, Professor Ian Olver, said results from the National Sun Protection Survey showed there had been a &#8220;remarkable turnaround&#8221; in attitudes to tanning. <o:p></o:p></span></span></p>
<p class="MsoNormal" style="text-align: justify"><span class="nnl"><span style="font-size: 10pt; color: black">&#8220;On one hand this is very encouraging, however the bad news is one in four teenagers is still getting burnt, not because they want to get a tan but because they are forgetting to protect themselves,&#8221; he said. &#8220;In contrast adults are clearly putting SunSmart behaviour into practice with a 31 per cent fall in adults reporting they were sunburnt since the last survey in 2004.&#8221; <o:p></o:p></span></span></p>
<p class="MsoNormal" style="text-align: justify"><span class="nnl"><span style="font-size: 10pt; color: black">Professor Olver said recent advertising campaigns were clearly having an impact, but an ongoing summer campaign was essential to reduce skin cancer death rates, which &#8220;rival the annual road toll.&#8221; <o:p></o:p></span></span></p>
<p class="MsoNormal" style="text-align: justify"><span class="nnl"><span style="font-size: 10pt; color: black">The National Sun Survey of 5085 adults and 652 teenagers around <st1:country-region w:st="on"><st1:place w:st="on">Australia</st1:place></st1:country-region> also found: <o:p></o:p></span></span></p>
<p class="MsoNormal" style="text-align: justify"><span class="nnl"><span style="font-size: 10pt; color: black">Girls were more likely to deliberately tan (29%) compared to boys (15%), however boys were more likely to get sunburnt (28%) than girls (19%), as more boys spent time outside in peak UV times and were less likely to use sunscreen - 14% of Australian adults aged 18-69 (1.8 million) and 24% of adolescents aged 12-17 (397,000) were sunburnt on an average summer weekend in 2006/7. <o:p></o:p></span></span></p>
<p class="MsoNormal" style="text-align: justify"><span class="nnl"><span style="font-size: 10pt; color: black">Chair of the Cancer Council&#8217;s National Skin Cancer Committee Mr Craig Sinclair said the research showed the Australian Government&#8217;s national skin cancer awareness campaign encouraged life-saving behaviours and should be run every summer<o:p></o:p></span></span></p>
<p class="akst_link"><a href="http://skincancerlive.com/?p=21&amp;akst_action=share-this"  title="E-mail this, post to del.icio.us, etc." id="akst_link_21" class="akst_share_link" rel="nofollow">Share This</a>
</p>]]></content:encoded>
			<wfw:commentRss>http://skincancerlive.com/2008/05/26/skin-cancer-6/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Scientific Articles about Skin Cancer</title>
		<link>http://skincancerlive.com/2008/05/26/scientific-articles-about-skin-cancer/</link>
		<comments>http://skincancerlive.com/2008/05/26/scientific-articles-about-skin-cancer/#comments</comments>
		<pubDate>Mon, 26 May 2008 16:24:30 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Scientific Articles about Skin Cancer]]></category>

		<guid isPermaLink="false">http://skincancerlive.com/archives/20</guid>
		<description><![CDATA[This page contains a list of citations for selected publications authored by CDC&#8217;s Division of Cancer Prevention and Control (DCPC) staff members. Fiscal years begin October 1 and end September 30; for example, fiscal year 2006 began October 1, 2005 and ended September 30, 2006.
Fiscal Year 2007
Glanz K, Buller DB, Saraiya M. Reducing ultraviolet radiation [...]]]></description>
			<content:encoded><![CDATA[<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">This page contains a list of citations for selected publications authored by CDC&#8217;s Division of Cancer Prevention and Control (DCPC) staff members. Fiscal years begin October 1 and end September 30; for example, fiscal year 2006 began October 1, 2005 and ended September 30, 2006.<o:p></o:p></span></p>
<h3 style="text-align: justify"><span style="font-size: 10pt; color: black">Fiscal Year 2007<o:p></o:p></span></h3>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Glanz K, Buller DB, Saraiya M. <a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;Cmd=ShowDetailView&amp;TermToSearch=17686155&amp;ordinalpos=1&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum"><span style="color: black; text-decoration: none">Reducing ultraviolet radiation exposure among outdoor workers: State of the evidence and recommendations.</span></a> <em><span style="font-style: normal">Environmental Health</span></em> 2007;6(1):22.<o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Saraiya M, Balluz L, Wen XJ, Joseph DA. <a href="http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5621a2.htm"><span style="color: black; text-decoration: none">Sunburn Prevalence Among Adults—United States, 1999, 2003, and 2004.</span></a> <em><span style="font-style: normal">MMWR</span></em> 2007;56(21);524–528.<o:p></o:p></span></p>
<h3 style="text-align: justify"><span style="font-size: 10pt; color: black">Fiscal Year 2006<o:p></o:p></span></h3>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Glanz K, Halpern AC, Saraiya M. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16549713&amp;query_hl=40&amp;itool=pubmed_DocSum"><span style="color: black; text-decoration: none">Behavioral and community interventions to prevent skin cancer: what works?</span></a> <em><span style="font-style: normal">Archives of Dermatology</span></em> 2006;142(3):356–360.<o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Jones SE, Saraiya M. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16536855&amp;query_hl=65&amp;itool=pubmed_DocSum"><span style="color: black; text-decoration: none">Sunscreen use among US high school students, 1999–2003.</span></a> <em><span style="font-style: normal">Journal of School Health</span></em>2006;76(4):150–153.<o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Oliveria SA, Saraiya M, Geller AC, Heneghan MK, Jorgensen C. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16326797&amp;query_hl=6&amp;itool=pubmed_DocSum"><span style="color: black; text-decoration: none">Sun exposure and risk of melanoma.</span></a> <em><span style="font-style: normal">Archives of Disease in Childhood</span></em> 2006;91(2):131–138.<o:p></o:p></span></p>
<h3 style="text-align: justify"><span style="font-size: 10pt; color: black">Fiscal Year 2005<o:p></o:p></span></h3>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Balk SJ, O&#8217;Connor KG, Saraiya M. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=15466105&amp;query_hl=19&amp;itool=pubmed_DocSum"><span style="color: black; text-decoration: none">Counseling parents and children on sun protection: A national survey of pediatricians.</span></a> <em><span style="font-style: normal">Pediatrics</span></em> 2004;114(4):1056–1064.<o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Glanz K, Saraiya M. <a href="http://www.cdc.gov/pcd/issues/2005/apr/04_0143.htm"><span style="color: black; text-decoration: none">Using evidence based community and behavioral interventions to prevent skin cancer: Opportunities and challenges for public health practice.</span></a> <em><span style="font-style: normal">Preventing Chronic Disease</span></em> 2005;2(2):A03.<o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Saraiya M, Glanz K, Briss PA, Nichols P, White C, Das D, Smith SJ, Tannor B, Hutchinson AB, Wilson KM, Gandhi N, Lee NC, Rimer B, Coates RC, Kerner JF, Hiatt RA, Buffler P, Rochester P. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15556744"><span style="color: black; text-decoration: none">Interventions to prevent skin cancer by reducing exposure to ultraviolet radiation: A systematic review.</span></a> <em><span style="font-style: normal">American Journal of Preventive Medicine</span></em> 2004;27(5):422–466.<o:p></o:p></span></p>
<h3 style="text-align: justify"><span style="font-size: 10pt; color: black">Fiscal Year 2004<o:p></o:p></span></h3>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Hall HI, Saraiya M, Thompson T, Hartman A, Glanz K, Rimer B. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14563911"><span style="color: black; text-decoration: none">Correlates of sunburn experiences among U.S. adults: Results of the 2000 National Health Interview Survey.</span></a> <em><span style="font-style: normal">Public Health Reports</span></em> 2003;118:540–549.<o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Saraiya M, Glanz K, Briss P, Nichols P, White C, Das D. <a href="http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5215a1.htm"><span style="color: black; text-decoration: none">Preventing skin cancer: Findings of the Task Force on Community Preventive Services on reducing exposure to ultraviolet light.</span></a> <em><span style="font-style: normal">MMWR Recommendations and Reports</span></em> 2003;52:1–12.<o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Saraiya M, Hall HI, Thompson T, Hartman A, Glanz K, Rimer B, Rose D. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15226039"><span style="color: black; text-decoration: none">Skin cancer screening among U.S. adults from 1992, 1998, and 2000 National Health Interview Surveys.</span></a> <em><span style="font-style: normal">Preventive Medicine</span></em> 2004;39:308–314.<o:p></o:p></span></p>
<h3 style="text-align: justify"><span style="font-size: 10pt; color: black">Fiscal Year 2003<o:p></o:p></span></h3>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Abroms L, Jorgensen CM, Southwell B, Emmons K, Geller A. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12564666"><span style="color: black; text-decoration: none">Gender differences in young adults&#8217; beliefs about sunscreen use.</span></a> <em><span style="font-style: normal">Health Behavior and Education</span></em> 2003;30:29–43.<o:p></o:p></span></p>
<h3 style="text-align: justify"><span style="font-size: 10pt; color: black">Fiscal Year 2002<o:p></o:p></span></h3>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Geller AC, Colditz A, Oliveria S, Emmons K, Jorgensen C, Aweh GN, Frazier AL. <a href="http://pediatrics.aappublications.org/cgi/content/full/109/6/1009"><span style="color: black; text-decoration: none">Use of sunscreen, sunburning rates, and tanning bed use among more than 10,000 U.S. children and adolescents.</span></a>* <em><span style="font-style: normal">Pediatrics</span></em> 2002;109:1009–1014.<o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Glanz K, Saraiya M, Wechsler H. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11995901"><span style="color: black; text-decoration: none">Guidelines for school programs to prevent skin cancer.</span></a> <em><span style="font-style: normal">MMWR</span></em> 2002;51(RR–4):1–18.<o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Hall HI, Jorgensen CM, McDavid K, Kraft JM, Breslow R. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12037264"><span style="color: black; text-decoration: none">Protection from sun exposure in U.S. white children ages 6 months to 11 years.</span></a> <em><span style="font-style: normal">Public Health Reports</span></em> 2001;116:353–361.<o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Hall HI, McDavid K, Jorgensen CM, Kraft JM. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11137768"><span style="color: black; text-decoration: none">Factors associated with sunburn in white children aged 6 months to 11 years.</span></a> <em><span style="font-style: normal">American Journal of Preventive Medicine</span></em> 2001;20:9–11.<o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Saraiya M, Hall HI, Uhler RJ. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=12121796&amp;query_hl=21&amp;itool=pubmed_docsum"><span style="color: black; text-decoration: none">Sunburn prevalence among adults in the United States, 1999.</span></a> <em><span style="font-style: normal">American Journal of Preventive Medicine</span></em> 2002;23:91–97.<o:p></o:p></span></p>
<h3 style="text-align: justify"><span style="font-size: 10pt; color: black">Fiscal Year 2001<o:p></o:p></span></h3>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Cokkinides VE, Davis KJ, Weinstock M, O&#8217;Connell M, Kalsebeek WD, Thun MJ, Wingo PA. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=11522153&amp;query_hl=23&amp;itool=pubmed_docsum"><span style="color: black; text-decoration: none">Sun exposure and sun protection behaviors and attitudes among U.S. youth, 11 to 18 years.</span></a> <em><span style="font-style: normal">Preventive Medicine</span></em> 2001;33:141–151.<o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Green C. CDC research reveals sun protection habits among young people. <em><span style="font-style: normal">Expose</span></em> 2001;5:22–23.<o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Hall HI, McDavid K, Jorgensen CM, Kraft JM. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11137768"><span style="color: black; text-decoration: none">Factors associated with sunburn in white children aged 6 months to 11 years.</span></a> <em><span style="font-style: normal">American Journal of Preventive Medicine</span></em> 2001;20:9–14.<o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Moore G. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11357281"><span style="color: black; text-decoration: none">A course of action on skin cancer.</span></a> <em><span style="font-style: normal">Business &amp; Health</span></em> April 2001; p. 40.<o:p></o:p></span></p>
<h3 style="text-align: justify"><span style="font-size: 10pt; color: black">Fiscal Year 2000<o:p></o:p></span></h3>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Green C, Jorgensen C. Reaching youth with skin cancer prevention. <em><span style="font-style: normal">Expose</span></em> 2000;4:14–16.<o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Jorgensen C, Wayman J, Green C, Gelb C. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10883937"><span style="color: black; text-decoration: none">Using health communications for primary prevention of skin cancer: CDC&#8217;s Choose Your Cover campaign.</span></a> <em><span style="font-style: normal">Journal of Women&#8217;s Health and Gender-Based Medicine</span></em> 2000;9:471–475.<o:p></o:p></span></p>
<p class="akst_link"><a href="http://skincancerlive.com/?p=20&amp;akst_action=share-this"  title="E-mail this, post to del.icio.us, etc." id="akst_link_20" class="akst_share_link" rel="nofollow">Share This</a>
</p>]]></content:encoded>
			<wfw:commentRss>http://skincancerlive.com/2008/05/26/scientific-articles-about-skin-cancer/feed/</wfw:commentRss>
		</item>
		<item>
		<title>SKIN CANCER</title>
		<link>http://skincancerlive.com/2008/05/26/skin-cancer-5/</link>
		<comments>http://skincancerlive.com/2008/05/26/skin-cancer-5/#comments</comments>
		<pubDate>Mon, 26 May 2008 16:23:55 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[SKIN CANCER -4]]></category>

		<guid isPermaLink="false">http://skincancerlive.com/archives/19</guid>
		<description><![CDATA[Finding out that you are losing your hair can be rather disturbing. It can be scary when you see that comb that’s full of your hair. The sight of it might make you seek out desperate measures to fight it. The first thing many people do is run out to get the latest hair loss [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; color: black">Finding out that you are losing your hair can be rather disturbing. It can be scary when you see that comb that’s full of your hair. The sight of it might make you seek out desperate measures to fight it. The first thing many people do is run out to get the latest hair loss fad, which is usually in the form of a shampoo or conditioner. While at first this may seem like a good idea, it’s important to take some time and find out what is causing the hair loss. By finding out the cause, you’ll be better equipped to fight it.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; color: black">There are many possible causes for sudden hair loss. One of the most common is that it’s a side effect of medication or a result of stress. Hormonal imbalances can also be another cause of hair loss. It’s also possible that it’s a symptom of another serious illness like diabetes, leukemia or lupus. It’s always best to consult a doctor before jumping to any conclusions. He’ll be able to tell you if it’s due to something that’s easy treatable, like stress. Or if it’s caused by another more serious illness. <o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; color: black">Assuming that it’s not caused by a major illness, there are many treatment options available. If it’s stress induced, treatment could be as simple as taking steps in reducing stress levels. There are also several products in the market today that can help. Rogaine and Propecia are two or the most popular medications available that can help. Hair transplants are also another popular option. While they are more expensive, you won’t have to wait that long for results. If you’re looking for a more “alternative” solution you can try herbal or Chinese remedies. While they aren’t quite as populate as some of the other treatments, they are a healthy alternative to fighting hair loss.<o:p></o:p></span></p>
<p class="akst_link"><a href="http://skincancerlive.com/?p=19&amp;akst_action=share-this"  title="E-mail this, post to del.icio.us, etc." id="akst_link_19" class="akst_share_link" rel="nofollow">Share This</a>
</p>]]></content:encoded>
			<wfw:commentRss>http://skincancerlive.com/2008/05/26/skin-cancer-5/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Skin Cancer in the News: New Treatment and Evaluation</title>
		<link>http://skincancerlive.com/2008/05/26/skin-cancer-in-the-news-new-treatment-and-evaluation/</link>
		<comments>http://skincancerlive.com/2008/05/26/skin-cancer-in-the-news-new-treatment-and-evaluation/#comments</comments>
		<pubDate>Mon, 26 May 2008 16:23:26 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Skin Cancer in the News: New Treatment and Evaluation]]></category>

		<guid isPermaLink="false">http://skincancerlive.com/archives/18</guid>
		<description><![CDATA[Skin cancer has made the news in recent weeks with two items that may affect you: 
1.        Imiquimod (Aldara™, by 3M) cream has been given approval for the treatment of superficial basal cell cancer. 
2.        The ABCD guide for the diagnosis of melanoma has been re-evaluated. New recommendations suggest ABCD and now E for describing [...]]]></description>
			<content:encoded><![CDATA[<p class="p-12" style="text-align: justify; line-height: normal"><span style="font-size: 10pt">Skin cancer has made the news in recent weeks with two items that may affect you: <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black"><span>1.<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">        </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black">Imiquimod (Aldara™, by 3M) cream has been given approval for the treatment of superficial basal cell cancer. <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black"><span>2.<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">        </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black">The ABCD guide for the diagnosis of melanoma has been re-evaluated. New recommendations suggest ABCD and now E for describing pigmented skin lesions that suggest cancer. <o:p></o:p></span></p>
<h2 style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black; font-style: normal">Imiquimod: How It Works<o:p></o:p></span></h2>
<p class="p-12" style="text-align: justify; line-height: normal"><span style="font-size: 10pt">Imiquimod (Aldara™) 5% cream is the first new treatment for superficial basal cell skin cancer in 30 years. The first line treatment for most skin cancers has been their surgical removal. This novel treatment uses another strategy. This drug, which is applied 5 times per week to the superficial basal cell cancer, produces an inflammation. This inflammation is the body&#8217;s immune response. The drug then directs cells in the skin to produce substances such as interferon and tumour necrosis factor, which is nature&#8217;s way of attacking viruses and cancers. <o:p></o:p></span></p>
<h2 style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black; font-style: normal">What Kind Of Skin Cancers Can It Treat?<o:p></o:p></span></h2>
<p class="p-12" style="text-align: justify; line-height: normal"><span style="font-size: 10pt">Actinic keratosis: <o:p></o:p></span></p>
<p class="p-12" style="text-align: justify; line-height: normal"><span style="font-size: 10pt">Basal cell cancer: <o:p></o:p></span></p>
<p class="p-r" style="text-align: justify; line-height: normal"><span style="font-size: 10pt; color: black">There are many subtypes of basal cell cancers. This cream has gained approval for the superficial type only as the atypical cells are close to the surface where the cream can readily penetrate. It is an exciting time when new ways of treatments are developed to challenge the conventional methods. With time and experience, such treatments might become commonplace, not just to treat skin cancers but perhaps to be applied to sun damaged skin in order to attempt to prevent new cancers.<o:p></o:p></span></p>
<p class="p-12" style="text-align: justify; line-height: normal"><span style="font-size: 10pt">Possible future indications: <o:p></o:p></span></p>
<p class="p-r" style="text-align: justify; line-height: normal"><span style="font-size: 10pt; color: black">Melanomas are the most serious types of skin cancers. The vast majority of these lesions are pigmented, only a small percentage are without a dark pigmentation. About ½ of these develop from preexisting moles and the others arise from normal, but usually sun damaged skin. Since the skin is visible, great efforts have been made to teach patients, the public, and all types of health professionals the features of melanomas. Melanomas that are treated early can be cured, so rapid diagnosis is best.<o:p></o:p></span></p>
<h2 style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black; font-style: normal">The New Evaluation Guide:<o:p></o:p></span></h2>
<p class="p-12" style="text-align: justify; line-height: normal"><span style="font-size: 10pt">The features of a lesion (mole) described as atypical and that should raise your suspicions are categorized as one of ABCD: <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black">A – Asymmetrical – the shape is uneven <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black">B – Border – the border is irregular <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black">C – Colour – the colour is dark brown or black <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black">D – Diameter – it should have a diameter of 0.6cm (the size of a pencil eraser) <o:p></o:p></span></p>
<p class="p-12" style="text-align: justify; line-height: normal"><span style="font-size: 10pt">There is a now an additional letter has been added: <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black">E – Evolving – the lesion is evolving or changing <o:p></o:p></span></p>
<p class="p-12" style="text-align: justify; line-height: normal"><span style="font-size: 10pt">The more complete the description the better, but we have to guard against making it too complicated. Another way of looking at these lesions could be: <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black">A – Atypical, out of step with other moles <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black">B – Black <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black">C – Colour variation within the lesion/changing mole <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black">D – Dark brown <o:p></o:p></span></p>
<p class="p-12" style="text-align: justify; line-height: normal"><span style="font-size: 10pt">In my practice, I see many melanomas that are smaller than 0.6cm, so don&#8217;t let size be the deciding factor. In other words, if you are suspicious of a mole, do not wait for a lesion to become 0.6cm before having it checked. <o:p></o:p></span></p>
<p class="akst_link"><a href="http://skincancerlive.com/?p=18&amp;akst_action=share-this"  title="E-mail this, post to del.icio.us, etc." id="akst_link_18" class="akst_share_link" rel="nofollow">Share This</a>
</p>]]></content:encoded>
			<wfw:commentRss>http://skincancerlive.com/2008/05/26/skin-cancer-in-the-news-new-treatment-and-evaluation/feed/</wfw:commentRss>
		</item>
		<item>
		<title>SKIN CANCER</title>
		<link>http://skincancerlive.com/2008/05/26/skin-cancer-4/</link>
		<comments>http://skincancerlive.com/2008/05/26/skin-cancer-4/#comments</comments>
		<pubDate>Mon, 26 May 2008 16:22:27 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[SKIN CANCER -3]]></category>

		<guid isPermaLink="false">http://skincancerlive.com/archives/17</guid>
		<description><![CDATA[Carcinogens are also often, but not necessarily, mutagens or teratogens. Carcinogens may cause cancer by altering cellular metabolism or damaging DNA directly in cells, which interferes with normal biological processes.
Aflatoxin B1, which is produced by the fungus Aspergillus flavus growing on stored grains, nuts and peanut butter, is an example of a potent, naturally-occurring microbial [...]]]></description>
			<content:encoded><![CDATA[<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Carcinogens are also often, but not necessarily, mutagens or teratogens. Carcinogens may cause cancer by altering cellular metabolism or damaging DNA directly in cells, which interferes with normal biological processes.<o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">Aflatoxin B1, which is produced by the fungus Aspergillus flavus growing on stored grains, nuts and peanut butter, is an example of a potent, naturally-occurring microbial carcinogen. Cooking protein-rich food at high temperatures, such as broiling or barbecuing meats, can lead to the formation of many potent carcinogens that are comparable to those found in cigarrette smoke (i.e., benzo[a]pyrene).Pre-cooking meats in a microwave oven for 2-3 minutes before broiling can help minimize the formation of these carcinogens..<o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black">For more information about the topic <strong><span style="font-family: "Times New Roman"; color: black">Carcinogen</span></strong>, read the full article at <a href="http://en.wikipedia.org/wiki/Carcinogen" target="_blank"><span style="color: black; text-decoration: none">Wikipedia.org</span></a>, or see the following related articles:<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><strong><span style="font-size: 10pt; font-family: "Times New Roman"; color: black"><a href="http://www.sciencedaily.com/articles/f/formaldehyde.htm"><span style="color: black; text-decoration: none">Formaldehyde</span></a></span></strong><span style="font-size: 10pt; color: black"> — The chemical compound formaldehyde (also known as methanal), is a gas with a strong pungent smell. Formaldehyde readily results from the incomplete &#8230;  &gt; <a href="http://www.sciencedaily.com/articles/f/formaldehyde.htm"><em><span style="color: black; font-style: normal; text-decoration: none">read more</span></em></a><o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><strong><span style="font-size: 10pt; font-family: "Times New Roman"; color: black"><a href="http://www.sciencedaily.com/articles/l/lung_cancer.htm"><span style="color: black; text-decoration: none">Lung cancer</span></a></span></strong><span style="font-size: 10pt; color: black"> — Lung cancer is a malignant tumour of the lungs. Most commonly it is bronchogenic carcinoma (about 90%). Lung cancer is the most lethal malignant <o:p></o:p></span></p>
<p class="akst_link"><a href="http://skincancerlive.com/?p=17&amp;akst_action=share-this"  title="E-mail this, post to del.icio.us, etc." id="akst_link_17" class="akst_share_link" rel="nofollow">Share This</a>
</p>]]></content:encoded>
			<wfw:commentRss>http://skincancerlive.com/2008/05/26/skin-cancer-4/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Actinic keratosis</title>
		<link>http://skincancerlive.com/2008/05/26/actinic-keratosis/</link>
		<comments>http://skincancerlive.com/2008/05/26/actinic-keratosis/#comments</comments>
		<pubDate>Mon, 26 May 2008 16:21:52 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Actinic keratosis]]></category>

		<guid isPermaLink="false">http://skincancerlive.com/archives/16</guid>
		<description><![CDATA[Actinic keratosis is also referred to as sun spots, solar keratosis, and pre-cancerous spots, or AK for short, is a crusty or scaly little spot that occurs on the skin, which can by as tiny as a pinhead to measuring more than an inch in diameter. Actinic keratoses can be the same color as the [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; color: black">Actinic keratosis is also referred to as sun spots, solar keratosis, and pre-cancerous spots, or AK for short, is a crusty or scaly little spot that occurs on the skin, which can by as tiny as a pinhead to measuring more than an inch in diameter. Actinic keratoses can be the same color as the skin, or reddish, pink, tan, or lighter or darker than the skin. The crusty or scaly surface is rough and dry, and hence can be easier to recognize by touching it rather than by looking at it. Actinic keratoses can be raised or flat and usually occurs on parts of the body that are exposed to the sun such as the face, neck, ears, on the forearms and hands, ears, and lips. On being exposed to the sun, they can often feel tender or prickly, or even itchy. If exposure to the sun is avoided for a few years, most of the actinic keratoses will subside on their own. <o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><strong><span style="font-size: 10pt; color: black">What Does the Occurrence of Actinic Keratoses Signify?</span></strong><span style="font-size: 10pt; color: black"> <o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; color: black">The occurrence of actinic keratoses is indicative of the development of the cancer of the skin, and hence is a pre-cancerous condition of the skin. But, the process of turning cancerous takes a number of years, besides very few of the actinic keratoses actually do turn malignant. When they do turn cancerous, the condition is known as squamous cell carcinoma. <o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; color: black">This type of cancer is not life threatening, generally, especially when there is early detection and treatment. In case that is not done, it can result in ulceration, bleeding, and infection, with the ulcers growing large in size and invading the tissues nearby, with chances of them metastasizing, or spreading to other parts of the body. <o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; color: black">Damage to the skin by the sun takes a long time to accumulate, often requiring a lifetime of exposure to the sun. Recent exposure to the sun or short periods in the sun usually does not lead to actinic keratosis or them developing into cancer of the skin. <o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; color: black">Those whose skin is fair, have gray, blue, or green eyes, and have red or blond hair are more susceptible to developing actinic keratosis, since they have less pigmentation of the skin, which acts as a protective barrier against the sun. Darker skinned people can also be affected if they expose their skin to the sun heavily. <o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><strong><span style="font-size: 10pt; color: black">What is the Treatment for Actinic Keratosis?</span></strong><span style="font-size: 10pt; color: black"> <o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; color: black">Prevention can be the best method of treating actinic keratoses, which means limiting being exposed to the sun. However, if actinic keratosis has already occurred, preventive methods can only be a means of not exacerbating it, since radiation from the sun has already caused damage to the skin. But, there are various methods of treatment that are quite effective in treating actinic keratosis, such as: <o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><strong><span style="font-size: 10pt; color: black">Cryosurgery:</span></strong><span style="font-size: 10pt; color: black"> This method involves applying liquid oxygen, either with a cotton-tipped applicator or a spraying device, to the actinic keratosis, which results in the lesions sloughing off. Anesthesia is not required and there is no bleeding involved. <o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><strong><span style="font-size: 10pt; color: black">Curettage:</span></strong><span style="font-size: 10pt; color: black"> A curette is used to scrape off the keratosis, along with cauterization to control the bleeding. <o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><strong><span style="font-size: 10pt; color: black">Creams:</span></strong><span style="font-size: 10pt; color: black"> Creams that contain 5-fluorouracil work by attacking the actinic keratoses directly. Although this treatment can cause the skin to become raw and red and some discomfort from the breakdown of the skin, however it is effective. Aldara, one of the newer medications that stimulates the immune system of the body. Solaraze gel, a non-steroidal medicine, is also quite effective. <o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><strong><span style="font-size: 10pt; color: black">Chemical Peels:</span></strong><span style="font-size: 10pt; color: black"> Acids are applied on the affected area, which causes the peeling off of the skin’s top layers. New skin usually grows within a week, and the soreness and redness go away within a few days.</p>
<p><strong>Photodynamic Therapy:</strong> This method of treating actinic keratosis is comparatively new, involving the injection of a chemical into a blood vessel, which collects in the actinic keratoses, which makes them sensitive to a special kind of light.<o:p></o:p></span></p>
<p class="akst_link"><a href="http://skincancerlive.com/?p=16&amp;akst_action=share-this"  title="E-mail this, post to del.icio.us, etc." id="akst_link_16" class="akst_share_link" rel="nofollow">Share This</a>
</p>]]></content:encoded>
			<wfw:commentRss>http://skincancerlive.com/2008/05/26/actinic-keratosis/feed/</wfw:commentRss>
		</item>
		<item>
		<title>The link between ozone and melanoma</title>
		<link>http://skincancerlive.com/2008/05/26/the-link-between-ozone-and-melanoma/</link>
		<comments>http://skincancerlive.com/2008/05/26/the-link-between-ozone-and-melanoma/#comments</comments>
		<pubDate>Mon, 26 May 2008 16:20:57 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[The link between ozone and melanoma]]></category>

		<guid isPermaLink="false">http://skincancerlive.com/archives/15</guid>
		<description><![CDATA[Researches and environmental studies have been telling that the Ultraviolet rays of sun are very harmful and cause deadly skin cancer. Generally the stratospheric Ozone layer acts as a shield between Sun and earth and blocks UV rays and helps the environment and people. But researches proves that, this Ozone layer has been depleting due [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; color: black">Researches and environmental studies have been telling that the Ultraviolet rays of sun are very harmful and cause deadly skin cancer. Generally the stratospheric Ozone layer acts as a shield between Sun and earth and blocks UV rays and helps the environment and people. But researches proves that, this Ozone layer has been depleting due to the heavy pollution. Since this layer is becoming weak day by day, the chances of UV rays reaching the earth increases day by day. This leads to the Skin cancer. Skin cancer is the fastest growing cancer than other cancers. So the death rate Is also High. Since the some part of the ozone layer is already damaged, nothing can be done. By gones be by gones. We must find steps in Saving the remaining part. Where there is a will there is way.We must protect ourselves from these harmful rays. The solution is in our hands only.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black"><span>1.<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">        </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black">We must take steps that make environment clean and green. <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black"><span>2.<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">        </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black">Reasons for pollutions are obvious. So repairing the old vehicles that cause extra smoke, banning the vehicles that are more prone to pollution, running healthy factories,planting are must and should activities in preventing the ozone layer from further depleting. <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black"><span>3.<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">        </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black">Use sunscreen lotions, umbrellas, fully covered clothes when you are going out. Because exposure to sun frequently increases the attack of skin cancer. Especially this effect is more in children. Studies have showed that those who suffered from sun burnt a lot, would suffer with skin cancer. So keep children away from sun.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black"><span>4.<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">        </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black">General awareness in people also helps in decreasing the skin cancer .By explaining the people about the skin cancer and the reasons for skin cancer, the importance of ozone layer and importance of non-polluted environment , we can also get good results.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; color: black">Conclusion: Thicker Ozone layer Weakens the chances of Skin Cancer. <o:p></o:p></span></p>
<p class="akst_link"><a href="http://skincancerlive.com/?p=15&amp;akst_action=share-this"  title="E-mail this, post to del.icio.us, etc." id="akst_link_15" class="akst_share_link" rel="nofollow">Share This</a>
</p>]]></content:encoded>
			<wfw:commentRss>http://skincancerlive.com/2008/05/26/the-link-between-ozone-and-melanoma/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Skin cancer</title>
		<link>http://skincancerlive.com/2008/05/26/skin-cancer-3/</link>
		<comments>http://skincancerlive.com/2008/05/26/skin-cancer-3/#comments</comments>
		<pubDate>Mon, 26 May 2008 16:19:45 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Skin cancer -2]]></category>

		<guid isPermaLink="false">http://skincancerlive.com/archives/14</guid>
		<description><![CDATA[NaturalNews) &#8220;TNF blocker&#8221; drugs used to treat rheumatoid arthritis increase a patient&#8217;s risk of contracting skin cancer, according to a new study published in the journal Arthritis &#38; Rheumatism.
Researchers compiled data from twice-yearly questionnaires filled out by 13,001 rheumatoid arthritis patients between 1998 and 2005, and found that those taking TNF blockers had a slightly [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; color: black">NaturalNews) &#8220;TNF blocker&#8221; drugs used to treat rheumatoid arthritis increase a patient&#8217;s risk of contracting skin cancer, according to a new study published in the journal <span>Arthritis &amp; Rheumatism.<o:p></o:p></span></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; color: black">Researchers compiled data from twice-yearly questionnaires filled out by 13,001 rheumatoid arthritis patients between 1998 and 2005, and found that those taking TNF blockers had a slightly higher risk of contracting skin cancer than patients not taking the medications.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; color: black">Because rheumatoid arthritis is an autoimmune disease, in which the body is attacked by its own immune system, TNF blocker drugs disrupt a critical immune pathway. As a result, the drugs are believed to expose patients to an increased risk of serious infections.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; color: black">The exact nature of the link to <a href="http://www.naturalnews.com/cancer.html"><span style="color: black; text-decoration: none">cancer</span></a> is still being investigated. The current study was the third to find an increased <a href="http://www.naturalnews.com/cancer_risk.html"><span style="color: black; text-decoration: none">cancer risk</span></a> associated with the use of TNF blockers.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; color: black">&#8220;Three major clinical trials, in their malignancy data, all have some indication there is a problem with <a href="http://www.naturalnews.com/skin_cancer.html"><span style="color: black; text-decoration: none">skin cancer</span></a> with these drugs,&#8221; said Mayo Clinic rheumatologist Tim Bongartz, who was not involved in the study. &#8220;This has huge implications in how we examine [and advise] these patients.&#8221;<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; color: black">Three kinds of TNF blockers have been approved for use in the <st1:country-region w:st="on"><st1:place w:st="on">United States</st1:place></st1:country-region>. Of these, most of the participants in the new study were taking Remicade, with most of the rest taking Enbrel and very few taking Humira.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; color: black">Lead researcher Frederick Wolfe, the director of the National Data Bank for Rheumatic Diseases, said that even with the increased cancer risk, there is no need for patients who need the <a href="http://www.naturalnews.com/medication.html"><span style="color: black; text-decoration: none">medication</span></a> to stop taking it.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; color: black">&#8220;It is a small overall risk and I don&#8217;t think people should be concerned,&#8221; he said.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span style="font-size: 10pt; color: black">Bongartz agreed, saying that even the increased risk of infection only means that doctors need to monitor patients who are taking TNF blockers more carefully.<o:p></o:p></span></p>
<p class="akst_link"><a href="http://skincancerlive.com/?p=14&amp;akst_action=share-this"  title="E-mail this, post to del.icio.us, etc." id="akst_link_14" class="akst_share_link" rel="nofollow">Share This</a>
</p>]]></content:encoded>
			<wfw:commentRss>http://skincancerlive.com/2008/05/26/skin-cancer-3/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Alternative Names</title>
		<link>http://skincancerlive.com/2008/05/26/alternative-names/</link>
		<comments>http://skincancerlive.com/2008/05/26/alternative-names/#comments</comments>
		<pubDate>Mon, 26 May 2008 16:18:55 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Alternative Names]]></category>

		<guid isPermaLink="false">http://skincancerlive.com/archives/13</guid>
		<description><![CDATA[Cancer - Skin
Skin cancer is the uncontrolled growth of skin cells. If left unchecked, these cancer cells can spread from the skin into other tissues and organs.
There are different types of skin cancer. Basal cell carcinoma is the most common. Melanoma is less common, but more dangerous.
Causes    
The outer layer of skin, the epidermis, is [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNormal" style="text-align: justify"><span class="minusone1"><strong><span style="font-size: 10pt; color: black" lang="EN">Cancer - Skin</span></strong></span><a name="Definition"></a><strong><span style="font-size: 10pt; color: black" lang="EN"><o:p></o:p></span></strong></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">Skin cancer is the uncontrolled growth of skin cells. If left unchecked, these cancer cells can spread from the skin into other tissues and organs.<o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">There are different types of skin cancer. Basal cell carcinoma is the most common. Melanoma is less common, but more dangerous.<o:p></o:p></span></p>
<p style="text-align: justify"><a name="Causes__incidence__and_risk_factors"></a><span class="minusone1"><strong><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">Causes</span></strong></span><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">    <o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">The outer layer of skin, the epidermis, is made up of different types of cells. Skin cancers are classified by the types of epidermal cells involved:<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black" lang="EN"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black" lang="EN"><a href="http://www.nlm.nih.gov/medlineplus/ency/article/000824.htm"><span style="color: black; text-decoration: none">Basal cell carcinoma</span></a> develops from abnormal growth of the cells in the lowest layer of the epidermis and is the most common type of skin cancer. <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black" lang="EN"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black" lang="EN"><a href="http://www.nlm.nih.gov/medlineplus/ency/article/000829.htm"><span style="color: black; text-decoration: none">Squamous cell carcinoma</span></a> involves changes in the squamous cells, found in the middle layer of the epidermis. <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black" lang="EN"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black" lang="EN"><a href="http://www.nlm.nih.gov/medlineplus/ency/article/000850.htm"><span style="color: black; text-decoration: none">Melanoma</span></a> occurs in the melanocytes (cells that produce pigment) and is less common than squamous or basal cell carcinoma &#8212; but more dangerous. It is the leading cause of death from skin disease. <o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">Skin cancers are sometimes classified as either melanoma or nonmelanoma. Basal cell carcinoma and squamous cell carcinoma are the most common nonmelanoma skin cancers. Other nonmelanoma skin cancers are <a href="http://www.nlm.nih.gov/medlineplus/ency/article/000661.htm"><span style="color: black; text-decoration: none">Kaposi&#8217;s sarcoma</span></a>, Merkel cell carcinoma, and cutaneous lymphoma.<o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">Skin cancer is the most common form of cancer in the Unites States. Known risk factors for skin cancer include the following:<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black" lang="EN"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black" lang="EN">Complexion - Skin cancers are more common in people with light-colored skin, hair, and eyes. <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black" lang="EN"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black" lang="EN">Genetics - Having a family history of melanoma increases the risk of developing this cancer. <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black" lang="EN"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black" lang="EN">Age - Nonmelanoma skin cancers are more common after age 40. <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black" lang="EN"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black" lang="EN">Sun exposure and <a href="http://www.nlm.nih.gov/medlineplus/ency/article/003227.htm"><span style="color: black; text-decoration: none">sunburn</span></a> - Most skin cancers occur on areas of the skin that are regularly exposed to sunlight or other ultraviolet radiation. This is considered the primary cause of all skin cancers. <o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">Skin cancer can develop in anyone, not only people with these risk factors. Young, healthy people &#8212; even those with with dark skin, hair, and eyes &#8212; can develop skin cancer.<o:p></o:p></span></p>
<p style="text-align: justify"><a name="Symptoms"></a><span class="minusone1"><strong><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">Symptoms</span></strong></span><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">    Skin cancers may have many different appearances. They can be small, shiny, or waxy, scaly and rough, firm and red, crusty or bleeding, or have other features. Therefore, anything suspicious should be looked at by a physician. See the individual articles on specific skin cancers for more information.<o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">Here are some features to look for:<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black" lang="EN"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><strong><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">Asymmetry:</span></strong><span style="font-size: 10pt; color: black" lang="EN"> one half of the abnormal skin area is different than the other half <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black" lang="EN"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><strong><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">Borders:</span></strong><span style="font-size: 10pt; color: black" lang="EN"> irregular borders <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black" lang="EN"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><strong><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">Color:</span></strong><span style="font-size: 10pt; color: black" lang="EN"> varies from one area to another with shades of tan, brown, or black (sometimes white, red, blue) <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black" lang="EN"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><strong><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">Diameter:</span></strong><span style="font-size: 10pt; color: black" lang="EN"> usually (but not always) larger than 6 mm in size (diameter of a pencil eraser) <o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">Use a mirror or have someone help you look on your back, shoulders, and other hard-to-see areas.<o:p></o:p></span></p>
<p style="text-align: justify"><a name="Treatment"></a><span class="minusone1"><strong><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">Treatment</span></strong></span><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">    <o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">Different types of skin cancer require different treatment approaches. See the specific type of skin cancer for information:<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black" lang="EN"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black" lang="EN">Basal cell carcinoma <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black" lang="EN"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black" lang="EN">Squamous cell carcinoma <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black" lang="EN"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black" lang="EN">Melanoma <o:p></o:p></span></p>
<p style="text-align: justify"><a name="Support_Groups"></a><span class="minusone1"><strong><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">Support Groups</span></strong></span><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">    <o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">For additional resources, see <a href="http://www.nlm.nih.gov/medlineplus/ency/article/002166.htm"><span style="color: black; text-decoration: none">cancer support group</span></a>.<o:p></o:p></span></p>
<p style="text-align: justify"><a name="Expectations__prognosis_"></a><span class="minusone1"><strong><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">Outlook (Prognosis)</span></strong></span><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">   <o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">The outlook depends on a number of factors, including the type of cancer and how quickly it was diagnosed. See the specific skin cancer articles for additional information.<o:p></o:p></span></p>
<p style="text-align: justify"><a name="Calling_your_health_care_provider"></a><span class="minusone1"><strong><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">When to Contact a Medical Professional</span></strong></span><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">    <o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">Any suspicious mole, sore, or skin growth should be looked at by a physician immediately. Take any changes in a mole or sudden growth of a skin lesion seriously.<o:p></o:p></span></p>
<p style="text-align: justify"><a name="Prevention"></a><span class="minusone1"><strong><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">Prevention</span></strong></span><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">    <o:p></o:p></span></p>
<p style="text-align: justify"><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">Minimizing sun exposure is the best way to prevent skin damage, including many types of skin cancer:<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black" lang="EN"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black" lang="EN">Protect your skin from the sun when you can &#8212; wear protective clothing such as hats, long-sleeved shirts, long skirts, or pants. <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black" lang="EN"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black" lang="EN">Try to avoid exposure during midday, when the sun is most intense. <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black" lang="EN"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black" lang="EN">Use sunscreen with an SPF of at least 15. Apply sunscreen at least one-half hour before sun exposure, and reapply frequently. <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><!--[if !supportLists]--><span style="font-size: 10pt; color: black" lang="EN"><span>—<span style="font-family: "Times New Roman"; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal">      </span></span></span><!--[endif]--><span style="font-size: 10pt; color: black" lang="EN">Apply sunscreen during winter months as well. <o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><strong><span style="font-size: 10pt; font-family: "Times New Roman"; color: black" lang="EN">Update Date: 10/26/2006</span></strong><span style="font-size: 10pt; color: black" lang="EN"> <o:p></o:p></span></p>
<p class="MsoNormal" style="text-align: justify"><span class="minustwo1"><span style="font-size: 10pt; color: black" lang="EN">Updated by: Michael S. Lehrer, M.D., Department of Dermatology, <st1:placetype w:st="on">University</st1:placetype> of <st1:placename w:st="on">Pennsylvania</st1:placename> Medical Center, <st1:place w:st="on"><st1:city w:st="on">Philadelphia</st1:city>, <st1:state w:st="on">PA.</st1:state></st1:place> Review provided by VeriMed Healthcare Network.</span></span><span style="font-size: 10pt; color: black"><o:p></o:p></span></p>
<p class="akst_link"><a href="http://skincancerlive.com/?p=13&amp;akst_action=share-this"  title="E-mail this, post to del.icio.us, etc." id="akst_link_13" class="akst_share_link" rel="nofollow">Share This</a>
</p>]]></content:encoded>
			<wfw:commentRss>http://skincancerlive.com/2008/05/26/alternative-names/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>
